Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:20:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page; the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study record, replacing the study details with a standard error message and site chrome. It includes a Home link and a revision note (Revision: v3.7.0).
    Difference
    20%
    Check dated 2026-09-20T22:21:03.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated from v3.6.5 to v3.6.6, reflecting a new page version.
    Difference
    0.0%
    Check dated 2026-08-30T21:43:11.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Adds sponsor/investigator information and links to study documents (e.g., Study Protocol and Statistical Analysis Plan), IPD sharing details and URLs, and PubMed references. It also includes MeSH terms and related indexing to better situate the trial within the scientific literature.
    Difference
    70%
    Check dated 2026-08-16T15:28:01.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the page, indicating a minor backend update to the page metadata. No study details or eligibility information appear to be affected.
    Difference
    0.0%
    Check dated 2026-08-09T10:56:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.